Clinical Trial Update: The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active "Drug: Crohn's Disease" [Phase 3]

View source ↗

Summary

A Phase 3 trial of Pentasa Sachet (mesalamine) for mucosal healing in mild-to-moderate Crohn's disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Pentasa Sachet (mesalamine)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Crohn's Disease | Phase 3 | Status: TERMINATED